Myristoylated Cathelicidin‐DM Fused With ANG1‐7: A Novel Self‐Assembling Antimicrobial Peptide for the Treatment and Mechanism of Diabetic Infected Wounds
Journal of Diabetes Research · 2025
DOI: 10.1155/jdr/9601959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Research, 2025. Verfasst von Rongqin Feng und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Northwest University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Wound Healing, Cathelicidins, Peptide Fragments, Angiotensin I. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic wounds, due to severe vascular dysfunction, persistent inflammatory responses, and susceptibility to microbial infections, exhibit delayed healing and pose a significant challenge to human health. Diabetic wounds face delayed healing and significant health challenges due to vascular dysfunction, persistent inflammation, and infection susceptibility. Therefore, the development of drugs with antibacterial capabilities, as well as the ability to effectively regulate inflammation and promote angiogenesis, is of great importance. In this study, a novel antibacterial peptide (named MYR‐DM‐ANG1‐7) was designed. It is composed of the coassembly of myristoylated antibacterial peptide cathelicidin‐DM and angiotensin 1‐7 (ANG 1‐7). This novel antibacterial peptide demonstrates antibacterial activity against both Escherichia coli and Staphylococcus aureus bacteria and can even effectively inhibit the formation of biofilms. In vitro experiments confirmed that MYR‐DM‐ANG1‐7 can promote the proliferation, migration, and angiogenesis of human umbilical vein endothelial cells (HUVECs), reduce the level of oxidative stress, alleviate the increase in mitochondrial membrane potential caused by high glucose (HG) and lipopolysaccharide (LPS), and decrease the expression of proinflammatory cytokines IL‐6 and TNF‐ α . Western blot experiments confirmed that MYR‐DM‐ANG1‐7 activates PI3K by targeting the membrane receptor Mas, thereby activating AKT, which ultimately promotes the activation of eNOS to produce nitric oxide (NO), thereby enhancing the angiogenic capacity of HUVECs. In vivo experiments showed that the local application of MYR‐DM‐ANG1‐7 significantly improved the healing of infected diabetic wounds in mice, including increased wound healing rate, reduced inflammatory cell infiltration, and promoted collagen fiber and blood vessel formation. In summary, this study successfully constructed a multifunctional novel self‐assembling antibacterial peptide that can effectively regulate oxidative stress, inflammation, and angiogenesis to promote the repair of diabetic infected wounds. This research provides a brand new self‐assembling lipopeptide therapeutic strategy for the treatment of diabetic infected wounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Northwest University, Xi'an, Shaanxi, China.
- Department of Burns and Cutaneous Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
ORCID-Profile: Rongqin Feng, Peng Wang, Li Fan, He Lu, Danna Yao, Panpan Sun, Zhonghua Liu, Fu Han, Xiaozhi Bai, Xuekang Yang, Juntao Han
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Feng, R., Wang, P., Fan, L., Lu, H., Yao, D., Sun, P., Liu, Z., Han, F., Bai, X., Yang, X., & Han, J. (2025). Myristoylated Cathelicidin‐DM Fused With ANG1‐7: A Novel Self‐Assembling Antimicrobial Peptide for the Treatment and Mechanism of Diabetic Infected Wounds. Journal of Diabetes Research. https://doi.org/10.1155/jdr/9601959
Vancouver
Feng R, Wang P, Fan L, Lu H, Yao D, Sun P, et al. Myristoylated Cathelicidin‐DM Fused With ANG1‐7: A Novel Self‐Assembling Antimicrobial Peptide for the Treatment and Mechanism of Diabetic Infected Wounds. Journal of Diabetes Research. 2025. doi:10.1155/jdr/9601959
BibTeX
@article{Feng2025,
author = {Feng, Rongqin and Wang, Peng and Fan, Li and Lu, He and Yao, Danna and Sun, Panpan and Liu, Zhonghua and Han, Fu and Bai, Xiaozhi and Yang, Xuekang and Han, Juntao},
title = {Myristoylated Cathelicidin‐DM Fused With ANG1‐7: A Novel Self‐Assembling Antimicrobial Peptide for the Treatment and Mechanism of Diabetic Infected Wounds},
journal = {Journal of Diabetes Research},
year = {2025},
doi = {10.1155/jdr/9601959}
}
EUVIMED